Matthew Harmelink
Impact in
-
- Neurogenetic and Muscular Disorders Research
-
- Epilepsy research and treatment
Papers in
-
- Muscle Physiology and Disorders 5
- Surgery 3
- Co-authors
- Emily Welby (1 shared paper)Allison D. Ebert (2 shared papers)Dominic B. Fee (1 shared paper)Priya Monrad (1 shared paper)Michael Weisgerber (1 shared paper)Donald E. Greydanus (1 shared paper)Harry T. Whelan (1 shared paper)Jun Ho Kim (1 shared paper)
- Journals
- Neuromuscular Disorders (2 papers)Neurology (1 paper)Pediatric Neurology (1 paper)Pediatric Dermatology (1 paper)Critical Care Clinics (1 paper)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Matthew Harmelink
11 papers receiving 102 citations
Peers
Comparison fields: 5 of 31
- Genetics 22
- Psychiatry and Mental health 26
- Neurology 19
- Microbiology 5
- Cell Biology 12
Countries citing papers authored by Matthew Harmelink
This map shows the geographic impact of Matthew Harmelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Harmelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Harmelink more than expected).
Fields of papers citing papers by Matthew Harmelink
This network shows the impact of papers produced by Matthew Harmelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Harmelink. The network helps show where Matthew Harmelink may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Harmelink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 30 | |
| 2 | 2021 | 18 | |
| 3 | 2017 | 17 | |
| 4 | 2015 | 13 | |
| 5 | 2022 | 7 | |
| 6 | 2019 | 5 | |
| 7 | 2019 | 4 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 3 | |
| 10 | 2015 | 3 | |
| 11 | 2024 | 1 | |
| 12 | 2025 | 0 |
About Matthew Harmelink
Matthew Harmelink is a scholar working on Molecular Biology, Surgery, Genetics, Genetics and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 105 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (5 papers), Neurogenetic and Muscular Disorders Research (3 papers), Genetic Neurodegenerative Diseases (2 papers), Neurological and metabolic disorders (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Systemic Sclerosis and Related Diseases (1 paper), Epilepsy research and treatment (1 paper) and Autoimmune Neurological Disorders and Treatments (1 paper). The work is most often cited by research in Genetics (22 citations), Psychiatry and Mental health (26 citations), Neurology (19 citations), Microbiology (5 citations) and Cell Biology (12 citations). Matthew Harmelink has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Emily Welby, Allison D. Ebert, Dominic B. Fee, Priya Monrad, Michael Weisgerber, Donald E. Greydanus, Harry T. Whelan, Jun Ho Kim, Wei-Liang Chen and Paul E. Barkhaus. Their work appears in journals such as Neuromuscular Disorders, Neurology, Pediatric Neurology, Pediatric Dermatology and Critical Care Clinics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.